| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.53 | 0.05 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.092 | 0.06 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |